カテゴリ： QYResearch, 世界, 消費財/食品

心臓病診断の世界市場2025年：心電図、血液検査、血管造影、コンピュータ心電計

■ 英語タイトル：Global Heart Disease Diagnosis Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7937）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7937
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[心臓病診断の世界市場2025年：心電図、血液検査、血管造影、コンピュータ心電計]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は心臓病診断のグローバル市場について調査・分析し、世界の心臓病診断市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（心電図、血液検査、血管造影、コンピュータ心電計）、用途別セグメント分析（病院、外来手術センター、診断センター）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、GE Healthcare、Hitachi Corporation、Koninklijke Philips NV、Midmark Corporation,、F Hoffmann-La Roche Ltd、Schiller AG、Siemens Healthineers、Toshiba Corporation、Welch Allyn Inc、Astrazenca PLC.などが含まれています。心臓病診断のグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、心臓病診断市場規模を算出する際に考慮しました。

・心臓病診断市場の概要
- 製品の定義
- 心臓病診断の種類別セグメント
- 世界の心臓病診断市場規模：タイプ別分析（心電図、血液検査、血管造影、コンピュータ心電計）
- 心臓病診断の用途別セグメント
- 世界の心臓病診断市場規模：用途別分析（病院、外来手術センター、診断センター）
- 世界の心臓病診断市場規模予測（2020年-2031年）
- 心臓病診断の平均価格推移（2020年-2031年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 心臓病診断市場の競争状況およびトレンド

・心臓病診断の地域別市場規模
- 北米の心臓病診断市場規模（2020年-2031年）
- 米国の心臓病診断市場規模（2020年-2031年）
- ヨーロッパの心臓病診断市場規模（2020年-2031年）
- アジア太平洋の心臓病診断市場規模（2020年-2031年）
- 中国の心臓病診断市場規模（2020年-2031年）
- 日本の心臓病診断市場規模（2020年-2031年）
- 韓国の心臓病診断市場規模（2020年-2031年）
- インドの心臓病診断市場規模（2020年-2031年）
- オーストラリアの心臓病診断市場規模（2020年-2031年）
- 中南米の心臓病診断市場規模（2020年-2031年）
- 中東・アフリカの心臓病診断市場規模（2020年-2031年）

・種類別セグメント：心電図、血液検査、血管造影、コンピュータ心電計
- 世界の心臓病診断のタイプ別販売量（2020年-2025年）
- 世界の心臓病診断のタイプ別売上（2020年-2025年）
- 世界の心臓病診断のタイプ別価格

・用途別セグメント：病院、外来手術センター、診断センター
- 世界の心臓病診断の用途別販売量（2020年-2025年）
- 世界の心臓病診断の用途別売上（2020年-2025年）
- 世界の心臓病診断の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
GE Healthcare、Hitachi Corporation、Koninklijke Philips NV、Midmark Corporation,、F Hoffmann-La Roche Ltd、Schiller AG、Siemens Healthineers、Toshiba Corporation、Welch Allyn Inc、Astrazenca PLC.

・産業チェーンと販売チャネルの分析
- 心臓病診断産業チェーン分析
- 心臓病診断の主要原材料
- 心臓病診断の販売チャネル
- 心臓病診断のディストリビューター
- 心臓病診断の主要顧客

・心臓病診断市場ダイナミクス
- 心臓病診断の業界動向
- 心臓病診断市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Heart Disease Diagnosis market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Heart Disease Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Heart Disease Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global manufacturers of Heart Disease Diagnosis include GE Healthcare, Hitachi Corporation, Koninklijke Philips NV, Midmark Corporation,, F Hoffmann-La Roche Ltd, Schiller AG, Siemens Healthineers, Toshiba Corporation and Welch Allyn Inc, etc. in 2024, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heart Disease Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heart Disease Diagnosis.
The Heart Disease Diagnosis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heart Disease Diagnosis market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heart Disease Diagnosis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
GE Healthcare
Hitachi Corporation
Koninklijke Philips NV
Midmark Corporation,
F Hoffmann-La Roche Ltd
Schiller AG
Siemens Healthineers
Toshiba Corporation
Welch Allyn Inc
Astrazenca PLC.
Segment by Type
ECG
Blood Test
Angiography
Computerized Cardiac Tomography
Segment by Application
Hospital
Ambulatory Surgery Center
Diagnostic Center
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heart Disease Diagnosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heart Disease Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Heart Disease Diagnosis Market Overview
1.1 Product Overview and Scope of Heart Disease Diagnosis
1.2 Heart Disease Diagnosis Segment by Type
1.2.1 Global Heart Disease Diagnosis Market Value Comparison by Type (2025-2031)
1.2.2 ECG
1.2.3 Blood Test
1.2.4 Angiography
1.2.5 Computerized Cardiac Tomography
1.3 Heart Disease Diagnosis Segment by Application
1.3.1 Global Heart Disease Diagnosis Market Value by Application: (2025-2031)
1.3.2 Hospital
1.3.3 Ambulatory Surgery Center
1.3.4 Diagnostic Center
1.4 Global Heart Disease Diagnosis Market Size Estimates and Forecasts
1.4.1 Global Heart Disease Diagnosis Revenue 2020-2031
1.4.2 Global Heart Disease Diagnosis Sales 2020-2031
1.4.3 Global Heart Disease Diagnosis Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Heart Disease Diagnosis Market Competition by Manufacturers
2.1 Global Heart Disease Diagnosis Sales Market Share by Manufacturers (2020-2025)
2.2 Global Heart Disease Diagnosis Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Heart Disease Diagnosis Average Price by Manufacturers (2020-2025)
2.4 Global Heart Disease Diagnosis Industry Ranking 2023 VS 2024 VS 2025
2.5 Global Key Manufacturers of Heart Disease Diagnosis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heart Disease Diagnosis, Product Type & Application
2.7 Heart Disease Diagnosis Market Competitive Situation and Trends
2.7.1 Heart Disease Diagnosis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Heart Disease Diagnosis Players Market Share by Revenue
2.7.3 Global Heart Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Heart Disease Diagnosis Retrospective Market Scenario by Region
3.1 Global Heart Disease Diagnosis Market Size by Region: 2020 Versus 2024 Versus 2025
3.2 Global Heart Disease Diagnosis Global Heart Disease Diagnosis Sales by Region: 2020-2031
3.2.1 Global Heart Disease Diagnosis Sales by Region: 2020-2025
3.2.2 Global Heart Disease Diagnosis Sales by Region: 2026-2031
3.3 Global Heart Disease Diagnosis Global Heart Disease Diagnosis Revenue by Region: 2020-2031
3.3.1 Global Heart Disease Diagnosis Revenue by Region: 2020-2025
3.3.2 Global Heart Disease Diagnosis Revenue by Region: 2026-2031
3.4 North America Heart Disease Diagnosis Market Facts & Figures by Country
3.4.1 North America Heart Disease Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Heart Disease Diagnosis Sales by Country (2020-2031)
3.4.3 North America Heart Disease Diagnosis Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Heart Disease Diagnosis Market Facts & Figures by Country
3.5.1 Europe Heart Disease Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Heart Disease Diagnosis Sales by Country (2020-2031)
3.5.3 Europe Heart Disease Diagnosis Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heart Disease Diagnosis Market Facts & Figures by Country
3.6.1 Asia Pacific Heart Disease Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Heart Disease Diagnosis Sales by Country (2020-2031)
3.6.3 Asia Pacific Heart Disease Diagnosis Revenue by Country (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Heart Disease Diagnosis Market Facts & Figures by Country
3.7.1 Latin America Heart Disease Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Heart Disease Diagnosis Sales by Country (2020-2031)
3.7.3 Latin America Heart Disease Diagnosis Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heart Disease Diagnosis Market Facts & Figures by Country
3.8.1 Middle East and Africa Heart Disease Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Heart Disease Diagnosis Sales by Country (2020-2031)
3.8.3 Middle East and Africa Heart Disease Diagnosis Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Heart Disease Diagnosis Sales by Type (2020-2031)
4.1.1 Global Heart Disease Diagnosis Sales by Type (2020-2025)
4.1.2 Global Heart Disease Diagnosis Sales by Type (2026-2031)
4.1.3 Global Heart Disease Diagnosis Sales Market Share by Type (2020-2031)
4.2 Global Heart Disease Diagnosis Revenue by Type (2020-2031)
4.2.1 Global Heart Disease Diagnosis Revenue by Type (2020-2025)
4.2.2 Global Heart Disease Diagnosis Revenue by Type (2026-2031)
4.2.3 Global Heart Disease Diagnosis Revenue Market Share by Type (2020-2031)
4.3 Global Heart Disease Diagnosis Price by Type (2020-2031)
5 Segment by Application
5.1 Global Heart Disease Diagnosis Sales by Application (2020-2031)
5.1.1 Global Heart Disease Diagnosis Sales by Application (2020-2025)
5.1.2 Global Heart Disease Diagnosis Sales by Application (2026-2031)
5.1.3 Global Heart Disease Diagnosis Sales Market Share by Application (2020-2031)
5.2 Global Heart Disease Diagnosis Revenue by Application (2020-2031)
5.2.1 Global Heart Disease Diagnosis Revenue by Application (2020-2025)
5.2.2 Global Heart Disease Diagnosis Revenue by Application (2026-2031)
5.2.3 Global Heart Disease Diagnosis Revenue Market Share by Application (2020-2031)
5.3 Global Heart Disease Diagnosis Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Heart Disease Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GE Healthcare Heart Disease Diagnosis Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Hitachi Corporation
6.2.1 Hitachi Corporation Corporation Information
6.2.2 Hitachi Corporation Description and Business Overview
6.2.3 Hitachi Corporation Heart Disease Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hitachi Corporation Heart Disease Diagnosis Product Portfolio
6.2.5 Hitachi Corporation Recent Developments/Updates
6.3 Koninklijke Philips NV
6.3.1 Koninklijke Philips NV Corporation Information
6.3.2 Koninklijke Philips NV Description and Business Overview
6.3.3 Koninklijke Philips NV Heart Disease Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Koninklijke Philips NV Heart Disease Diagnosis Product Portfolio
6.3.5 Koninklijke Philips NV Recent Developments/Updates
6.4 Midmark Corporation,
6.4.1 Midmark Corporation, Corporation Information
6.4.2 Midmark Corporation, Description and Business Overview
6.4.3 Midmark Corporation, Heart Disease Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Midmark Corporation, Heart Disease Diagnosis Product Portfolio
6.4.5 Midmark Corporation, Recent Developments/Updates
6.5 F Hoffmann-La Roche Ltd
6.5.1 F Hoffmann-La Roche Ltd Corporation Information
6.5.2 F Hoffmann-La Roche Ltd Description and Business Overview
6.5.3 F Hoffmann-La Roche Ltd Heart Disease Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.5.4 F Hoffmann-La Roche Ltd Heart Disease Diagnosis Product Portfolio
6.5.5 F Hoffmann-La Roche Ltd Recent Developments/Updates
6.6 Schiller AG
6.6.1 Schiller AG Corporation Information
6.6.2 Schiller AG Description and Business Overview
6.6.3 Schiller AG Heart Disease Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Schiller AG Heart Disease Diagnosis Product Portfolio
6.6.5 Schiller AG Recent Developments/Updates
6.7 Siemens Healthineers
6.6.1 Siemens Healthineers Corporation Information
6.6.2 Siemens Healthineers Description and Business Overview
6.6.3 Siemens Healthineers Heart Disease Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Siemens Healthineers Heart Disease Diagnosis Product Portfolio
6.7.5 Siemens Healthineers Recent Developments/Updates
6.8 Toshiba Corporation
6.8.1 Toshiba Corporation Corporation Information
6.8.2 Toshiba Corporation Description and Business Overview
6.8.3 Toshiba Corporation Heart Disease Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Toshiba Corporation Heart Disease Diagnosis Product Portfolio
6.8.5 Toshiba Corporation Recent Developments/Updates
6.9 Welch Allyn Inc
6.9.1 Welch Allyn Inc Corporation Information
6.9.2 Welch Allyn Inc Description and Business Overview
6.9.3 Welch Allyn Inc Heart Disease Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Welch Allyn Inc Heart Disease Diagnosis Product Portfolio
6.9.5 Welch Allyn Inc Recent Developments/Updates
6.10 Astrazenca PLC.
6.10.1 Astrazenca PLC. Corporation Information
6.10.2 Astrazenca PLC. Description and Business Overview
6.10.3 Astrazenca PLC. Heart Disease Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Astrazenca PLC. Heart Disease Diagnosis Product Portfolio
6.10.5 Astrazenca PLC. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heart Disease Diagnosis Industry Chain Analysis
7.2 Heart Disease Diagnosis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heart Disease Diagnosis Production Mode & Process
7.4 Heart Disease Diagnosis Sales and Marketing
7.4.1 Heart Disease Diagnosis Sales Channels
7.4.2 Heart Disease Diagnosis Distributors
7.5 Heart Disease Diagnosis Customers
8 Heart Disease Diagnosis Market Dynamics
8.1 Heart Disease Diagnosis Industry Trends
8.2 Heart Disease Diagnosis Market Drivers
8.3 Heart Disease Diagnosis Market Challenges
8.4 Heart Disease Diagnosis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Heart Disease Diagnosis Market Value Comparison by Type (2025-2031) & (US$ Million)
Table 2. Global Heart Disease Diagnosis Market Value Comparison by Application (2025-2031) & (US$ Million)
Table 3. Global Heart Disease Diagnosis Market Competitive Situation by Manufacturers in 2024
Table 4. Global Heart Disease Diagnosis Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Heart Disease Diagnosis Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Heart Disease Diagnosis Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Heart Disease Diagnosis Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Heart Disease Diagnosis Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Heart Disease Diagnosis, Industry Ranking, 2023 VS 2024 VS 2025
Table 10. Global Key Manufacturers of Heart Disease Diagnosis, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Heart Disease Diagnosis, Product Type & Application
Table 12. Global Key Manufacturers of Heart Disease Diagnosis, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Heart Disease Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Disease Diagnosis as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Heart Disease Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Heart Disease Diagnosis Sales by Region (2020-2025) & (K Units)
Table 18. Global Heart Disease Diagnosis Sales Market Share by Region (2020-2025)
Table 19. Global Heart Disease Diagnosis Sales by Region (2026-2031) & (K Units)
Table 20. Global Heart Disease Diagnosis Sales Market Share by Region (2026-2031)
Table 21. Global Heart Disease Diagnosis Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Heart Disease Diagnosis Revenue Market Share by Region (2020-2025)
Table 23. Global Heart Disease Diagnosis Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Heart Disease Diagnosis Revenue Market Share by Region (2026-2031)
Table 25. North America Heart Disease Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Heart Disease Diagnosis Sales by Country (2020-2025) & (K Units)
Table 27. North America Heart Disease Diagnosis Sales by Country (2026-2031) & (K Units)
Table 28. North America Heart Disease Diagnosis Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Heart Disease Diagnosis Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Heart Disease Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Heart Disease Diagnosis Sales by Country (2020-2025) & (K Units)
Table 32. Europe Heart Disease Diagnosis Sales by Country (2026-2031) & (K Units)
Table 33. Europe Heart Disease Diagnosis Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Heart Disease Diagnosis Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Heart Disease Diagnosis Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Heart Disease Diagnosis Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Heart Disease Diagnosis Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Heart Disease Diagnosis Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Heart Disease Diagnosis Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Heart Disease Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Heart Disease Diagnosis Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Heart Disease Diagnosis Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Heart Disease Diagnosis Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Heart Disease Diagnosis Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Heart Disease Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East & Africa Heart Disease Diagnosis Sales by Country (2020-2025) & (K Units)
Table 47. Middle East & Africa Heart Disease Diagnosis Sales by Country (2026-2031) & (K Units)
Table 48. Middle East & Africa Heart Disease Diagnosis Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Heart Disease Diagnosis Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Heart Disease Diagnosis Sales (K Units) by Type (2020-2025)
Table 51. Global Heart Disease Diagnosis Sales (K Units) by Type (2026-2031)
Table 52. Global Heart Disease Diagnosis Sales Market Share by Type (2020-2025)
Table 53. Global Heart Disease Diagnosis Sales Market Share by Type (2026-2031)
Table 54. Global Heart Disease Diagnosis Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Heart Disease Diagnosis Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Heart Disease Diagnosis Revenue Market Share by Type (2020-2025)
Table 57. Global Heart Disease Diagnosis Revenue Market Share by Type (2026-2031)
Table 58. Global Heart Disease Diagnosis Price (US$/Unit) by Type (2020-2025)
Table 59. Global Heart Disease Diagnosis Price (US$/Unit) by Type (2026-2031)
Table 60. Global Heart Disease Diagnosis Sales (K Units) by Application (2020-2025)
Table 61. Global Heart Disease Diagnosis Sales (K Units) by Application (2026-2031)
Table 62. Global Heart Disease Diagnosis Sales Market Share by Application (2020-2025)
Table 63. Global Heart Disease Diagnosis Sales Market Share by Application (2026-2031)
Table 64. Global Heart Disease Diagnosis Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Heart Disease Diagnosis Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Heart Disease Diagnosis Revenue Market Share by Application (2020-2025)
Table 67. Global Heart Disease Diagnosis Revenue Market Share by Application (2026-2031)
Table 68. Global Heart Disease Diagnosis Price (US$/Unit) by Application (2020-2025)
Table 69. Global Heart Disease Diagnosis Price (US$/Unit) by Application (2026-2031)
Table 70. GE Healthcare Corporation Information
Table 71. GE Healthcare Description and Business Overview
Table 72. GE Healthcare Heart Disease Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. GE Healthcare Heart Disease Diagnosis Product
Table 74. GE Healthcare Recent Developments/Updates
Table 75. Hitachi Corporation Corporation Information
Table 76. Hitachi Corporation Description and Business Overview
Table 77. Hitachi Corporation Heart Disease Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Hitachi Corporation Heart Disease Diagnosis Product
Table 79. Hitachi Corporation Recent Developments/Updates
Table 80. Koninklijke Philips NV Corporation Information
Table 81. Koninklijke Philips NV Description and Business Overview
Table 82. Koninklijke Philips NV Heart Disease Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Koninklijke Philips NV Heart Disease Diagnosis Product
Table 84. Koninklijke Philips NV Recent Developments/Updates
Table 85. Midmark Corporation, Corporation Information
Table 86. Midmark Corporation, Description and Business Overview
Table 87. Midmark Corporation, Heart Disease Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Midmark Corporation, Heart Disease Diagnosis Product
Table 89. Midmark Corporation, Recent Developments/Updates
Table 90. F Hoffmann-La Roche Ltd Corporation Information
Table 91. F Hoffmann-La Roche Ltd Description and Business Overview
Table 92. F Hoffmann-La Roche Ltd Heart Disease Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. F Hoffmann-La Roche Ltd Heart Disease Diagnosis Product
Table 94. F Hoffmann-La Roche Ltd Recent Developments/Updates
Table 95. Schiller AG Corporation Information
Table 96. Schiller AG Description and Business Overview
Table 97. Schiller AG Heart Disease Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Schiller AG Heart Disease Diagnosis Product
Table 99. Schiller AG Recent Developments/Updates
Table 100. Siemens Healthineers Corporation Information
Table 101. Siemens Healthineers Description and Business Overview
Table 102. Siemens Healthineers Heart Disease Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Siemens Healthineers Heart Disease Diagnosis Product
Table 104. Siemens Healthineers Recent Developments/Updates
Table 105. Toshiba Corporation Corporation Information
Table 106. Toshiba Corporation Description and Business Overview
Table 107. Toshiba Corporation Heart Disease Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Toshiba Corporation Heart Disease Diagnosis Product
Table 109. Toshiba Corporation Recent Developments/Updates
Table 110. Welch Allyn Inc Corporation Information
Table 111. Welch Allyn Inc Description and Business Overview
Table 112. Welch Allyn Inc Heart Disease Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Welch Allyn Inc Heart Disease Diagnosis Product
Table 114. Welch Allyn Inc Recent Developments/Updates
Table 115. Astrazenca PLC. Corporation Information
Table 116. Astrazenca PLC. Description and Business Overview
Table 117. Astrazenca PLC. Heart Disease Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Astrazenca PLC. Heart Disease Diagnosis Product
Table 119. Astrazenca PLC. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Heart Disease Diagnosis Distributors List
Table 123. Heart Disease Diagnosis Customers List
Table 124. Heart Disease Diagnosis Market Trends
Table 125. Heart Disease Diagnosis Market Drivers
Table 126. Heart Disease Diagnosis Market Challenges
Table 127. Heart Disease Diagnosis Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Heart Disease Diagnosis
Figure 2. Global Heart Disease Diagnosis Market Value Comparison by Type (2025-2031) & (US$ Million)
Figure 3. Global Heart Disease Diagnosis Market Share by Type in 2024 & 2031
Figure 4. ECG Product Picture
Figure 5. Blood Test Product Picture
Figure 6. Angiography Product Picture
Figure 7. Computerized Cardiac Tomography Product Picture
Figure 8. Global Heart Disease Diagnosis Market Value Comparison by Application (2025-2031) & (US$ Million)
Figure 9. Global Heart Disease Diagnosis Market Share by Application in 2024 & 2031
Figure 10. Hospital
Figure 11. Ambulatory Surgery Center
Figure 12. Diagnostic Center
Figure 13. Global Heart Disease Diagnosis Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Heart Disease Diagnosis Market Size (2020-2031) & (US$ Million)
Figure 15. Global Heart Disease Diagnosis Sales (2020-2031) & (K Units)
Figure 16. Global Heart Disease Diagnosis Average Price (US$/Unit) & (2020-2031)
Figure 17. Heart Disease Diagnosis Report Years Considered
Figure 18. Heart Disease Diagnosis Sales Share by Manufacturers in 2024
Figure 19. Global Heart Disease Diagnosis Revenue Share by Manufacturers in 2024
Figure 20. The Global 5 and 10 Largest Heart Disease Diagnosis Players: Market Share by Revenue in 2024
Figure 21. Heart Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2020 VS 2024
Figure 22. Global Heart Disease Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Heart Disease Diagnosis Sales Market Share by Country (2020-2031)
Figure 24. North America Heart Disease Diagnosis Revenue Market Share by Country (2020-2031)
Figure 25. United States Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Heart Disease Diagnosis Sales Market Share by Country (2020-2031)
Figure 28. Europe Heart Disease Diagnosis Revenue Market Share by Country (2020-2031)
Figure 29. Germany Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Heart Disease Diagnosis Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Heart Disease Diagnosis Revenue Market Share by Region (2020-2031)
Figure 36. China Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Heart Disease Diagnosis Sales Market Share by Country (2020-2031)
Figure 46. Latin America Heart Disease Diagnosis Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Heart Disease Diagnosis Sales Market Share by Country (2020-2031)
Figure 51. Middle East & Africa Heart Disease Diagnosis Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Heart Disease Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Heart Disease Diagnosis by Type (2020-2031)
Figure 56. Global Revenue Market Share of Heart Disease Diagnosis by Type (2020-2031)
Figure 57. Global Heart Disease Diagnosis Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Heart Disease Diagnosis by Application (2020-2031)
Figure 59. Global Revenue Market Share of Heart Disease Diagnosis by Application (2020-2031)
Figure 60. Global Heart Disease Diagnosis Price (US$/Unit) by Application (2020-2031)
Figure 61. Heart Disease Diagnosis Value Chain
Figure 62. Heart Disease Diagnosis Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

※参考情報

心臓病診断は、心臓や血管に関する疾患を特定し、診断するための重要なプロセスです。心臓病は、世界中で多くの人々の命に影響を及ぼす主要な健康問題の一つであり、早期発見と適切な治療が求められます。心臓病の診断は、臨床的な評価、画像診断、血液検査、心電図などの多様な手法を使用して行われます。これにより、医師は患者の心臓の健康状態を正確に把握し、適切な治療法を選択することが可能になります。

心臓病の特徴としては、症状が多様であることが挙げられます。胸痛、息切れ、動悸、不整脈などが一般的な症状として知られています。これらの症状は、心筋梗塞や心不全、狭心症、心房細動など、様々な種類の心臓病に見られます。特に心筋梗塞は急激な症状が現れるため、緊急対応が必要となります。これらの症状は、一見すると他の病気と似ていることもあり、迅速な診断が求められます。

心臓病の種類は多岐にわたりますが、大きく分けると以下のようなものがあります。まずは虚血性心疾患で、これは心筋が十分な血液を受け取れないことにより生じる疾患です。心筋梗塞や狭心症が含まれます。次に、弁膜症があり、心臓の弁に異常が発生することにより血液の流れが妨げられる疾患です。また、心不全は心臓のポンプ機能が低下し、体の各組織に十分な血液が供給されなくなる状態を指します。更に、心臓リズムの異常である不整脈も重要な種類に含まれ、これは心臓が不規則に拍動することにより、血液の循環が影響を受けます。

心臓病診断の用途としては、主に病歴の評価、身体検査、画像診断を通じて、患者の心臓の状態を把握することがあります。これにより、心臓病のリスクファクターを特定し、予防策を講じることができます。例えば、高血圧や高コレステロール、糖尿病などは心臓病のリスクを高める要素として知られており、これらを管理することが心臓病の予防に繋がります。さらに、診断を行うことで、適切な治療法を選択し、患者の生活の質を向上させることが可能になります。

心臓病の診断に関連する技術は、日々進化しています。一つ目は心電図（ECG/EKG）で、これは心臓の電気的活動を記録し、リズムや異常を視覚的に示すものです。心電図は心臓病の初期診断に非常に有用であり、特に不整脈の発見に使われます。また、心エコー検査は超音波を使用し、心臓の構造や機能をリアルタイムで観察することができます。心臓の弁の状態や心筋の収縮力を評価するために用いられます。さらに、冠動脈造影は、冠動脈の状態を詳細に確認するための非常に重要な手法で、狭窄や閉塞の有無を判定します。

近年では、CTスキャンやMRIといった画像診断技術も心臓病の診断に役立っています。これらは高解像度で心臓の病変を捉え、他の診断技術では見逃される微細な異常を発見することが可能です。特に、CT冠動脈造影は非侵襲的に冠動脈の状態を評価できるため、危険因子を持つ患者のスクリーニングに広く用いられています。

血液検査も心臓病診断の一環であり、特定のバイオマーカーを測定することで心筋の損傷や炎症の程度を判断します。トロポニンやBNP（B型 natriuretic peptide）などの物質は心臓の状態を反映する重要な指標とされ、心筋梗塞や心不全の診断において重要な役割を果たします。

心臓病診断は、患者の健康を守るために極めて重要な分野であり、常に新しい技術や治療法の模索が続けられています。新興の人工知能（AI）技術や機械学習は、診断プロセスの効率化や精度向上に寄与する可能性があり、今後の進展が期待されています。AIを用いたデータ解析は、大量の患者データから特徴を抽出し、診断支援システムを構築することが可能です。これにより、医師はより迅速かつ正確に診断を下すことができ、患者に対する医療サービスも向上するでしょう。

心臓病診断の重要性を理解することで、普段の生活においても心臓の健康を意識し、適切な生活習慣を維持することが大切です。定期的な健康診断を受け、リスクファクターを把握することによって、心臓病の予防につながります。心臓病の早期発見と治療は、患者の予後を大きく改善する要因となりますので、医療従事者と患者が一体となって健康を守ることが重要です。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 心臓発作診断のグローバル市場（2023年-2030年）：心電図、血液検査、血管造影、心臓断層撮影法、その他
  • 心臓構造イメージングのグローバル市場：心エコー図、血管造影
  • 世界の腎機能検査市場2023-2030：クリアランス検査、血液検査、尿検査、希釈・濃縮検査薬、その他
  • 卵巣がん診断のグローバル市場（2023年-2030年）：画像診断、血液検査、生検、その他
  • 処置用トレイのグローバル市場2023-2030：手術室、血管造影、眼科
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7937 )"心臓病診断の世界市場2025年：心電図、血液検査、血管造影、コンピュータ心電計" (英文：Global Heart Disease Diagnosis Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。